| term candidates: 1300 |
| RAKFKQLL |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| overt leukemia |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Tc2 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| eosinophil |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Th development |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| antiphosphotyrosine immunoblotting |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| frame shift |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class II gene expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| enhancer function |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| il-2 mrna |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| reasons |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| nuclear targeting sequence |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| nonsense mutation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| inflammatory synovitis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 69 bp upstream |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| private |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| calcium channel blocker |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| LMP-1 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| STAT activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| receptor promoter |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| human erythroleukemia cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| RAKFKQLLQ |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| myf3 gene |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| c-myc mRNA level |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| immunoblotting |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| proximal position |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cellular gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| TFIID complex |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| positive cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| skin |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| MHC class II mRNA |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| synergistic induction |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| RNA target |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| trans-acting factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| gene transcription |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| alpha-subunit |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| upstream stimulatory factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| lymphoid specific gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| transcription factor, activated protein-1 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| gel mobility shift |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| il-2 mrna expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| TRAF binding motif |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| cdc-2 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cell-free processing system |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| presence |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| thromboxane receptor promoter activity |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| cytoplasmic extract |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| fetal hemoglobin in sickle cell anemia |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 327 aa protein |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| triflusal |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat T cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| il-3 promoter |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| transient transfection assay |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cell cycle |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class II transcription |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| locus control region |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| binding activity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| TAL1 mRNA |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell stimulation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| M-CSF |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| status |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| heptamer motif |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| enzyme |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| situ hybridization |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| phosphatase |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| exogenous il-12 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| TAL1 gene rearrangement |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| transcriptional activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cis element |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| context |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| nf-at-1 element |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| retinoblastoma control element |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell transformation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| pbmc |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell activator |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| chemotactic migration rate |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| nature |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
TERM |
TERM |
| T-cell malignancy |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| platelet glycoprotein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| receptor number |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| LDL |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| sodium salicylate |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| c-myc regulation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| nucleotide insertion |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| bacterium |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| social factor |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| lymphocyte |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| promoter factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| RNA polymerase II repeat |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
TERM |
| thyroid gland |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| rate |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| STAT signaling pathway |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell maturation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| bulbar conjunctiva |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| TcR delta mRNA |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
TERM |
| race |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| ubiquitin-protein ligase |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| monocyte mitochondrial 1 alpha-hydroxylase |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| GM-CSF |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| transcriptional response |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| coagulation protease |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| surface expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| biological phenomenon |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| polyclonal antiserum |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| lymphoid cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| LDL-receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| apoplexy |
TERM |
TERM |
TERM |
TERM |
NON-TERM |
TERM |
| phosphorylated form |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| human activation antigen |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| bcl-2 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| people |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| afternoon |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| T-cell antigen receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| source |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| T-cell regulatory cytokine |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| il-3 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| chromatin |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nerve growth factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| TFIIB |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| enhancer-binding protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell cycle progression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| signal-induced activation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| U-937 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| PHA-induced proliferation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| tyrosine phosphorylation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| transcriptional start site |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| circadian pacemaker |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| inducible expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nuclear matrix attachment |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| immunological variable involved |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| nf-kappa b-dependent cytokine gene expression |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| LNCaP cell |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell acute lymphoblastic leukemia |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| suprachiasmatic nuclei |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| humoral immunity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| functional characterization |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| activator protein-2 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| phorbol 12-myristate 13-acetate |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| human monocytic cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| mouse osteocalcin gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| hemoglobinization |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ES cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat line |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| STAT 4 transcription factor |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| ring |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| viral pathogenesis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| TRAF association |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| coexpression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| regulatory protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| RALDH2 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| tumor necrosis factor alpha |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MCP-1 RNA |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| cell lines |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| AP-1 transcription |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell DNA |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| chromatin-dependent process |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| alpha-helix |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| long term |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| T-cell specificity |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell costimulation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| direct |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| PHA activation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| cytotoxic cytokine synthesis |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| workshop |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| steroid-mediated cell death |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| bone marrow |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| intestinal calcium absorption |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| cellular transcription factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| activated t cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class II expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| tepoxalin |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| intrauterine contraception |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| p50 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| second enhancer |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| clonal expansion |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| putative transcription factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| c-myc mRNA accumulation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| puzzle |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| HB-EGF expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| chronic inflammatory reaction |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| c-myc oncogene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| mature p50 subunit |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| necessity |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| phosphorylation level |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| myelomonocytic cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| synthetic peptide substrate |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| hypothyroid relative |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
TERM |
| nucleotide sequence |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| B cell lymphoma |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| endothelial cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| vernal keratoconjunctivitis |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| thymocyte |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| epithelium |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| STAT serine phosphorylation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| syncytia |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cortisol depletion |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| supply |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| nf-atp |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| antigen receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ifn-gamma-activated sequence |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| panel |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| point mutation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ikb alpha |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| ubiquitin-proteasome system |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell leukemia |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nf-at-1 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat crude extract |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| tyrosine |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cerebral cortex |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| paper |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| TFIID binding site |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| oxidative signalling |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| distal element upstream |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| reactive oxygen intermediate production |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| cytoplasm |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| c-jun expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| hypercalciuria |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| heterogeneous clinical manifestations |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| Th1 clone |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| lymph node |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| signal-dependent activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ubiquitin |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| U-937 cell |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| ataxia-telangiectasia |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| antitumor agent |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| activated il-2 expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| leukemia |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| polyclonal antibody |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| il-2 secretion |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| dose-dependent manner |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cellular proliferation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| RNA display |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class II gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| evening |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| proteolytic degradation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| c-myb |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| major regulatory factor |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| Egr-1 binding site |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| HB9 homeodomain |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| high density lipoprotein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| U937 monocytic cell line |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| repression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| il-2 gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| person |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| ES cell system |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| higher-affinity site |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| STAT transcription factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| restriction fragment length polymorphism |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell biology |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| UL55 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| differential lymphokine expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| transcription initiation site |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| human leukocyte |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ERK kinase |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| complex enhancer |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| upstream promoter element |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| signal-transmitting receptor |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| TcR gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| STAT 6 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| nuclear protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| table |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| thyroid hormone |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nuclear kinase |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| c-myc probe |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| chicken erythrocyte factor |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| UF-1 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| dehydroepiandrosterone |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| purified viral material |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| LMP-1 protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| mean dissociation constant |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| T-cell population |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| inflammatory infiltrate |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| platelet function |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ced-3 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| acute hepatic injury |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| major gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Th0 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| gonadotropin-releasing hormone |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| GATA-4 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| RAKFKQLLQ-specific CTL |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| T-cell receptor stimulation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| p130 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| vascular cell adhesion molecule-1 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nuclear matrix |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| macrophage activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| inverted duplication |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| arthritis patient |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| solution |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| seconds |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| web |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| vascular injury |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| differentiation marker |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| proteasome inhibitor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Th1 response |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| LMP-1 promoter |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| disadvantage |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| apoptotic pathway |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| country |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| house |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| anti-inflammatory activity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| potent activator |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| octamer-dependent enhancer |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| regulatory functions |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| K562 cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| il-2 promoter |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| mononuclear phagocyte |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| sequence motif |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| B cell Ig secretion |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| T lymphocyte |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| phagocytosis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 5'-flanking region |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| c-myb protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| protein synthesis-independent |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| lymphokine |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| location |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| lymphokine gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nuclear extract |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| STAT DNA-binding activity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| society |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| T-antigen |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| human cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| hematopoiesis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| transcriptional factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| effector function |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| benefits |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| chromosomal protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cell cycle entry |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| focus |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| TRAF binding domains |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| retinoic acid |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| survey |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| U2 snRNA |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| RNA elongation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| article |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
TERM |
TERM |
| ability |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| ERK activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| intracellular trafficking |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| epithelial cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| binding site |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| application |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| liver injury |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| TAL1 gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| calcium-dependent manner |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| RNA polymerase III |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| early gene expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| exon-intron structure |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| positive-negative regulation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class II DRA promoter |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| egr-1 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| immunoglobulin heavy chain |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| binding sites |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| endogenous c-myb expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| power |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| ionomycin |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| period |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| biphasic kinetics |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| HB9 protein |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell gene expression |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| T-cell nuclear protein complex |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| T-cell receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 503-amino-acid-long acidic protein |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| growth factor receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| U86 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| parental cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| mitochondria |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| binding site selection |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| dose-dependent tyrosine phosphorylation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell accumulation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| RNA extraction |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| attack |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| short term |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| nuclear hormone receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 1.5 g metyrapone |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| target cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| LMP promoter |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| mitogen |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| gp 160 |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
TERM |
| c-myc expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| hematopoietic transcription factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| globin gene expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell gene activation |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| Ad5wt |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| immunodeficiency syndrome |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| glucocorticoid receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell receptor loci |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| simian virus 40 enhancer |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| down-regulation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| chromatin structure level |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| dephosphorylation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| estrogen receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| octamer-dependent enhancer activity |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| constitutive expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| plasmacytoma cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| myeloid cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| TRAF interaction domain |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| autostimulatory loop |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| pathological model |
TERM |
NON-TERM |
TERM |
TERM |
NON-TERM |
TERM |
| STAT tyrosine phosphorylation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| western blot analysis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| lox promoter |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| causal relationship |
TERM |
NON-TERM |
TERM |
TERM |
NON-TERM |
TERM |
| trans- dominant negative inhibitor |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| c-myc RNA |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| phosphorylation event |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| 5' end |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cis-acting sequence |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| microtubule |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MCP-1 gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| leukocyte |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| intracellular signalling agents |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| support |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| phorbol myristate acetate |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| AT464 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| flagellum |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| heterologous promoter |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| selectin family |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| packaging |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| RNA synthesis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| eosinophil cationic protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| growth-related metabolism |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| ifn inducible expression |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| c-myc mRNA |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 5' flanking region |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cytokine gene expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| c-myc gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| malignancy |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| igh |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| il-12 expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| human adenovirus |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| UDG expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| transcription start site |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| destruction |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| granulopoiesis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| U937 differentiation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| nf-kappa b complex |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| kinetics |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| whole-cell binding assay |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| osteoblast-specific gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| children |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| leukemic cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| jak kinase |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| amino acid 279 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| thyroid hormone receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell epitope |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| K562 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 28-bp core region |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| 14q32.1 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| hours |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| pathology |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| chemokine receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| trans-activation domain |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| MCP-1 expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| homodimer |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| flutamide |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| GM-CSF gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cytoplasmic inhibitor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| helix-loop-helix |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| basal transcription |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell type |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| HB24 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class II density |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| T-cell IL-5 synthesis |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| constitutive transcription factor |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class II compartment |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| regulatory element |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell immortalization |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| thymocyte-specific gene expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| overexpression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| dendritic cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| U5 region |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| intestinal hyperabsorption |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| western blotting |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| LEF-1 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| enhancer element |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| viral gene expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| transcriptional activity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ERK MAPKS |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| cases |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| granulocyte-macrophage colony-stimulating factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| advantage |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| phorbol-12-myristate-13-acetate |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| p105 precursor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| platelet |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ATGCAAAT |
TERM |
TERM |
TERM |
TERM |
NON-TERM |
TERM |
| cellular protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| concept |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| 15-lox gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| cytokine production |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| receptor complex |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| long terminal repeat |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| duration |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| rapid expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| human immunodeficiency virus |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| adhesion molecule |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| amino-terminal region |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| age |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| peptide |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cell mediated immune response |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| transactivating capacity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| intranuclear environment |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| p50 nf-kappa b1 |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| nf-kappa b activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cyclooxygenase/5-lipoxygenase anti-inflammatory compound |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| B lymphocyte |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nf-kappa b expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| hormone binding domain |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Ad12 13S mRNA |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| antiphosphotyrosine |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class I |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ets-1 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat HB24 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| proliferative response |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| viral gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| repressor activity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| U9-IIIB |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| TcR delta gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| tax transgenic mouse model |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| literature |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| trifluoromethylketone |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat T-cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| immunoregulatory cytokine |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| target |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| T lymphocyte activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cell death |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| AhR mRNA |
TERM |
TERM |
TERM |
TERM |
NON-TERM |
TERM |
| lower-affinity site |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| protein expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| erythroid cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| STAT 1 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| lymphocyte proliferation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| thromboxane receptor gene expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat J6 |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| c-myb oncogene product |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| transcriptional control |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ikb alpha phosphorylation |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| murine system |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat T lymphocyte |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| HB-EGF mRNA |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| M-CRF |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| electrophoretic mobility shift |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nonmyeloid cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| HB-EGF |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| leukemic cell infiltration |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell activation response element |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| B lymphocyte differentiation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| talk |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| MHC class II gene silencing |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| inactive cytoplasmic complex |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| RNA splicing |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| postmenopausal women |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| viral replication |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| PGE2 action |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| immunosuppressive agents |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| alpha-tocopherol |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| chloramphenicol acetyl transferase reporter gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| lymphocyte activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| il-2 gene expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| GATA-3 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| STAT pathway |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| immunoblot analysis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| antiinflammatory agent |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| lymphoid enhancer-binding factor 1 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| intravenous injection |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class II transactivator |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| inducible phosphorylation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 560 bp upstream |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| hybridization accessibility |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| transactivation domain |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| secretion |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| organizer |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| B lymphocyte monoclonicity |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
TERM |
| beta-estradiol |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| effector cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| extracellular signal |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| PHA-activated PBL |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| connection |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| UL49 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| nonhematopoietic lineage |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cellular mechanism |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cell cycle-associated gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| inhibitor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| estrogen |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| PG-B6p |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| glucocorticoid receptor function |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| binding assay |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| AP-1 element |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| response |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| interleukin-2 receptor-gamma |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| cytolytic resistance |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| heterologous syncytia |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| nf-kappa b-activating cytokine |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| sex |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| thymocyte-specific gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| immunosuppressive effect |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Egr-1 induction |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| TFIID |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| antioncogenic transcription factor interferon regulatory factor |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| transmigration |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cytokine expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| reporter gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| intracellular free calcium concentration |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| hematopoietic cell lineage |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| phosphorylation site |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| potential |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| tumor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| mammalian homologue |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| gamma c expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| U937 macrophage cell line |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| non-sequence-specific |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| acute myocardial infarction |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nf-kappa b |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Th cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| amino acid domain |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| signal transducer |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| fibroblast |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| vascular endothelium |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| artery wall |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| lymphoid cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell differentiation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| STAT activity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| breast cancer control |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
TERM |
| ribonucleoprotein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| transcriptional activator |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| M-CSF gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| differentiation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| oxidative stress |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| TcR |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| glutamine synthetase induction |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| TcR stimulation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| transient expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| B lymphocyte stimulation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| absorptive hypercalciuria |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| subepithelium |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| plasmid |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| PHA-induced T-cell mitogenesis |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| UAS3 |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| Egr-1 mRNA |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell homeostasis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| spleen |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| lysis mechanism |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| U-937 monoblastic cell line |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| PHA treatment |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| B lymphocyte cell line |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| systemic lupus erythematosus |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| protein-protein interaction |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| monocyte binding |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| tumor site |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| glucocorticoid |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| transcription activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| inflammatory cytokine |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| UAS2 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nf-at |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| repression domain |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cell lineage |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| GM-CSF receptor alpha promoter |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| il-10 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| neutrophil |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Th1 cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| morning |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| regulatory region |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class 1 gene expression |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| electrophoretic mobility shift assay |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| management |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| histone h5 gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| surface receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| kinase |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Egr-1 mRNA expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| c-myb proto-oncogene product |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| TFIIE beta |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell growth |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| basal level |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| haematopoietic system |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cytotoxicity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| RNA polymerase II |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| human herpesvirus 6 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| hybridization pattern |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cellular activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| effects |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| AP-1 activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| uninfected cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| circulating monocyte |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| transfected cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 150 nucleotides upstream |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| translocation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| interleukin-2 secretion |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 3' portion |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cell membrane |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| U-937 cell line |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| life |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| T-cell cDNA |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| atherosclerosis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| B lymphocyte Ig secretion |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| isoform |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| high-affinity binding site |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| peroxidase-antiperoxidase technique |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
TERM |
| transcriptional stimulation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| system |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| synthetic peptide |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nf-il6 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| igh enhancer regulation |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| monocyte |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| regulatory switch |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| PGE2 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| il-2 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cytokine modulating activity |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| il-12 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| inhibitory protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| truncation mutant |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell receptor gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| premature termination |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| rheumatoid arthritis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| M-CSF protein |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| immunoregulatory gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| peripheral blood lymphocyte |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| signal transduction |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| autoimmunity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| viral transcriptional transactivator |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| HBD fragment |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| UCSD-AML1 |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| ligand-inducible phosphorylation |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| transcription factor function |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| reporter construct |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| U937 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| in vitro treatment |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| U937 monocytic line |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| nuclear factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ifn-stimulated gene expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| constitutively expressed transcription factor |
TERM |
NON-TERM |
TERM |
TERM |
NON-TERM |
TERM |
| macrophage |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 15-lipoxygenase (lox) gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| STAT transcription |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| zinc finger protein binding region |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| Th1 cytokine |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Ala618 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| basal brain |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| phosphorylation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| exclusion |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| tumor necrosis factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| chicken homolog |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nf-kappa b binding |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| monocyte chemotaxis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell dysfunction |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| intronic enhancer |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| membrane-proximal region |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| rank |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| PGE2 modulation |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| K562 cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| il-2 promoter activation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| promoter activity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nf-at dna binding activity |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| constitutive phosphorylation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cytokine receptor gamma chain (gamma c) gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| UCSD-AML1 cell line |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| neutrophil adhesion |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| aminothiol compound |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| extracellular stimulation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| menstrual cycle |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| pathogenesis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| TAL1 allele |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| Th1 cell development |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| endogenous gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| positive regulatory element |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| megakaryocytic gene expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| promoter region |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| p53-conjugating ligase |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| endothelium |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| c-myc protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class I H-2Kb promoter |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| TcR delta locus |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| tumor necrosis factor-alpha |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| osteocalcin promoter |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| organization |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| gamma c |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| inducer-mediated degradation |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| deoxycholate treatment |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| test |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| leukocyte adhesion molecule |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class II gene-specific transcription activator |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| il-2 promoter activity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cytotoxic cytokine |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| igh enhancer |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| c-jun |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| murine homolog |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| virus production |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| GM-CSF enhancer |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| U937 cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 14q11 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cytokine receptor gamma chain |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| repressor element |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| immunocytochemistry |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| protein level |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell lineage |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cysteamine |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| calcineurin |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| HBV mRNA |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| RNA transcript |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell lysate |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| rhythm |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| administration |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| seven transmembrane receptor |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| nuclear targeting |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| bound kinase |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| cytokine gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| hypothalamic-pituitary-adrenal system |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| peripheral circulation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| TFIIE alpha |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| phorbol ester |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Th1 development |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell function |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| question |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| T-cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| LMP gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| PFP5a |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| hand |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| transient cotransfection |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nonopsonic phagocytosis |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| pathophysiology |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ifn-gamma |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| situ hybridization technique |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| lipid oxidation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| tumor growth |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| direct-repeat palindrome |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| cellular growth |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| UBP |
TERM |
TERM |
TERM |
TERM |
NON-TERM |
TERM |
| anti-inflammatory agent |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| RNA |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| GM-CSF TATA box |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| M-CSF receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ubiquitous polypeptide |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| bacterial lipopolysaccharide |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| glycosylation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nucleosome-assembly system |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| MHC class II signaling |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| HBV gene expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| progesterone receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| speculation |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| mutant sequence |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| erythroid differentiation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| hepatoma cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell mediated response |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
TERM |
| Jurkat T cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| lymphoblastoid cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| enhancer activity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| U937 monocytic cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cell proliferation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| transmission electron microscopy |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| promoter-binding protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| subendothelial space |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| il-3 promoter-linked reporter construct |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| oxidative species |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell receptor complex |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat CD4+ cell line |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| transgenic mouse model |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| trail |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| receptor activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| mouse fibroblastic cell line |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| nuclear inhibitory protein |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| bcl-xl |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| atherosclerotic plaque |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| turn |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| follicular phase |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| B cell differentiation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| transcriptional regulation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell response |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nuclear translocation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| retrovirus |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| pokeweed mitogen |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| expression pattern |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| thyrocyte |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| cytokine |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| RNA splice |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| AP1-binding site |
TERM |
NON-TERM |
TERM |
TERM |
NON-TERM |
TERM |
| immunohistochemistry |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| androgen receptor behavior |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| c-myc mRNA induction |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| cyclic amp |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| TAL1 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| chloramphenicol acetyl transferase |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| viral encoded protein |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| antigen recognition |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class II inducibility |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| alternative splicing |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| plant |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| allele |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat T cell complementary DNA |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| culture medium |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Egr-1 expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| steroid receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| extension |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| HAEC |
TERM |
NON-TERM |
TERM |
TERM |
NON-TERM |
TERM |
| bipartite nuclear localization signal |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| microtubular assembly |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| murine embryogenesis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| phosphotyrosine |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nucleosome |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| tax expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| human estrogen receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| c-myc allele |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 40-bp region |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| 380 bp upstream |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ERK |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cortisol |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Ad5E1A234-243 |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| il-2 production |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| lysate |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| heterodimer |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nucleus |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| lymphoid-specific transcription factor |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| ets family |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| certain types |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| fluorescence in situ hybridization |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| brain ischemia |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| death-promoting activity |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| antiandrogen drug |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat T-cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| il-2 repression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| transactivation assay |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| peripheral blood |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| antigenic challenge |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| lipopolysaccharide |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| tyk2 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| gamma interferon |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| M-CSF mRNA |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| zone |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| 30 base pairs upstream |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell clonal expansion |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| frame |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| 5' flanking genomic clone |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| T-cell clone |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| il-2 expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cell-free system |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat expression library |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| TFIIH |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| androgen receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| sequence element |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| minimal lox promoter fragment |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| variations |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| Egr-1 RNA |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| orientations |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| proximal promoter region |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| acute fulminant hepatitis |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| monocytic cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| attempt |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| control cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| gene expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| protein tyrosine phosphorylation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| protein product |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell transcription factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| flow cytometry |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| HBB |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| treatment |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| B cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| radiation-induced apoptosis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| lymphoid development |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| genomic clone |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| damage |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| purpose |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| reactive oxygen intermediate |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| Th1 phenotype |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell cDNA library |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cysteamine treatment |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| RNA processing |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| STAT 5 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| steroid mediated lysis |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| breakdown |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| intracellular killing |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| human papillomavirus |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| accumulation |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
| UDG promoter |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| asymptomatic infection |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat cell model |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| promoter-proximal position |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| cycloheximide |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| reporter gene activity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| B cell Ag receptor |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| Egr-1 gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| B cell activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| interleukin-2 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class II antigen |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| p65 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| interleukin-3 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| human chromosome |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| immunolabeling |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| GM-CSF promoter |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| enzymatic activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| transcriptional activation domain |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| RNA analysis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| isolation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| history |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| rapid phosphorylation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| U937 promonocytic cell |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| transcription factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| reduction |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| T-cell apoptosis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class 1 gene |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| LMP-1 E2RE |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| technology |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| equimolar heterodimerization |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| computer |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| effort |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| time |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| T-cell development |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| thromboxane receptor |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| northern hybridization |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| hematopoietic cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| K44M |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| monocytic cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| free radical production/oxidative stress |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| p53 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| alpha-hydroxyprogesterone |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| liver function |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| calcitriol action |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| demonstration |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| U3 region |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| transcription efficiency |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| reactive oxygen intermediate formation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| antiparallel mode |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| HB9 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| cell culture |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| immunofluorescence colocalization |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| B lymphocyte function |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| AP3-L site |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| ostensible immune stimulation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| order |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| commitment |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| APL cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell mitogenesis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| differential gene expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 5' portion |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| HBB transcription |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| gut hyperabsorption |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| peripheral blood mononuclear cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| dexamethasone |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| northern blot analysis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| plasma cortisol |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell prolymphocytic leukemia |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| inhibitory effect |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell mitogen |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| serum level |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| translation initiation codon |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| thromboxane receptor gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| alkaline phosphatase |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| autoantibody |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| human peripheral blood mononuclear cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| viral and cellular gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| B cell NHL |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| staphylococcal enterotoxin |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| p50 subunit |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| microtubule disruption |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| human lymphocyte |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| secondary factor |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| inducible transcription |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| non-proliferative state |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| bacteria |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| GATA3 gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| gamma-globin |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| phorbol 12-myristate 13-acetate-inducible transcription |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| salicylate |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| p50/p65 heterodimer |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| molecular mass |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ubiquitin-carrier protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| promoter function |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| U937 adhesion |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| operative kinase |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| ibuprofen |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell antigen |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| PG-B6 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| consensus sequence |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| mitogenic activation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell lymphoma |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| difference |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| radical scavenger |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| pathway |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| c-myc |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| tissue-specific down-regulation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| eosinophils |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| 200-bp enhancer domain |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| tumour suppressor p53 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| LMP-1 mutant |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| conversion |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| STAT protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ifn-induced nk cell killing |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| RALDH2 expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| immunoprecipitation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class I gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| size |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| il-6 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| glutamine synthetase |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MCP-1 induction |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| ATTTGCAT |
TERM |
TERM |
TERM |
TERM |
NON-TERM |
TERM |
| production |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| human inflammatory diseases |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| mononuclear blood cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| interleukin-1 beta converting enzyme |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| HAuCl3 |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| post-transcription regulation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell surface molecule |
TERM |
TERM |
TERM |
NON-TERM |
TERM |
TERM |
| Egr-1 site |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| c-myc promoter |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| chloramphenicol acetyltransferase |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| immunosuppressive agent |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| interleukin-1 receptor synthesis |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| MCP-1 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| recombinant protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| PGE2 production |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class II gene regulatory factor |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| mutational analyses |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ifn |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| serum transaminase |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| infected monocyte |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| activated cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cell gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| balance |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| UDG |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| isolated nuclei |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| n-terminus |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| lymphoblast |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| nf-kappa b binding activity |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| estrogen-mediated activation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| GATA-3 gene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| words |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| safety |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| UL21 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat T cells |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| differentiated plasma cell |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| flagella |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| K562 cancer cell |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| oligonucleotide |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| proline |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| luciferase |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| conserved cis-acting sequence |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| antiserum |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| glucocorticoid replacement |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| UL75 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| ligand-induced tyrosine phosphorylation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| STAT family |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| jun protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| apoptosis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| hydroxyurea |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| p53-independent pathway |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| RALDH2 gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| minutes |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| name |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| cell surface expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| stone-forming condition |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| adenovirus |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| virus transcription |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| PG490 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| pathophysiological relevance |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| erected wing gene product |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| oncogenesis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cis-acting element |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| involvement |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| technique |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| chromosome 14 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| calcitriol |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| ifn-gamma production |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| signal transduction mechanism |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| c-myb mRNA |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| human monocyte |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| TFIIA |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| chemotaxis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| B cell IgE synthesis |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| costimulation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| survival-promoting activity |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| phorbol ester treatment |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| supershift assay |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| investigation |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| isotype-matched antibody |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| transient stimulation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| TRAF aggregation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| t(14;14) translocation |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| GATA-3 protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| effector domain |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| breast cancer patient |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell recognition |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cell surface molecule |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| altruistic suicide |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| gamma-globin promoter |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| kinase activity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| tissue-specific fashion |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| sequence analysis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| LMP-1 molecule |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| erythroid cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| multipotent progenitor cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| pili |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| requirement |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| tumor control |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| UAS1 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| non-cytokine gene |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| leukocyte adhesion |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| contribution |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| nf-kappa b activity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| postinduction repression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| zinc finger protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| TAM |
TERM |
TERM |
TERM |
TERM |
NON-TERM |
TERM |
| ATTTA |
TERM |
TERM |
TERM |
TERM |
NON-TERM |
TERM |
| HB24 mRNA |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| ligand-induced phosphorylation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| PFP9a20 |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| blocking factor |
TERM |
TERM |
TERM |
TERM |
NON-TERM |
TERM |
| MHC class II |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell protein |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| histone h5 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Egr-1 transgene |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell signal |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| multisubunit adhesion receptor |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| GM-CSF element |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| fetal hemoglobin |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| monoclonal antibody |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| platelet morphogenesis |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| alpha-tocopherol treatment |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| myeloid lineage |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| inducible early growth response protein |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| TAL1 expression |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| interferon receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| MHC class II gene activation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| TAL1 transcription |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| putative new retrovirus |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| MHC class II induction |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| osteoblast nuclear extract |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| human gamma-globin promoter |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| U2 snRNA transcription |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| brain |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
| ERK pathway |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| progesterone |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| c-myc mRNA expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| cell nuclei |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| indomethacin |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| positions |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| octamer motif |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cell extract |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| trifluoperazine |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| HB9 gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| Jurkat cell extract |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| low density lipoprotein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| hybridization |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| immunoelectron microscopy |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| U-937 cell adhesion |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| chromosome translocation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| stimulated cell |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| interleukin-1 receptor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| steroid hormone activation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| nuclear factor-mu negative regulator |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| LDL-receptor gene |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| eosinophil lineage |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| selection |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| LNCaP |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| tat protein |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| cell line |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| monocyte gene expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| p105 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| B cell NFAT complex |
TERM |
NON-TERM |
TERM |
TERM |
NON-TERM |
NON-TERM |
| inflammatory synovial microenvironment |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| U89 |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| standard |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| osteoblast-specific cis-acting element |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| proteasome |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell proliferation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| ligand-inducible degradation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| site-directed mutagenesis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| proteolysis |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| pair |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
| il-4 |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell nuclear extract |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
NON-TERM |
| interferon-gamma |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| functional receptor number |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
TERM |
| dihydrotestosterone |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| UAS1 binding sites |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| transcriptional induction |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| T-cell receptor activation |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| syncytium formation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| Egr-1 gene expression |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| abstract |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
TERM |
TERM |
| antioxidant activity |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| UL50 |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| gel retardation assay |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| PGE2 synthesis |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| bone density |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| STAT induction |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| c-myc gene amplification |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| GATA3 transcription unit |
TERM |
NON-TERM |
TERM |
NON-TERM |
TERM |
NON-TERM |
| glucocorticoid-mediated induction |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| appearance |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| initiation binding repressor |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| tissue-specific manner |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| human tissue |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| competition |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| ionomycin treatment |
TERM |
NON-TERM |
TERM |
TERM |
TERM |
TERM |
| subsequent degradation |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| granulocyte macrophage colony-stimulating factor |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| candidate |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
NON-TERM |
TERM |
| heterotrans-activation |
TERM |
NON-TERM |
TERM |
NON-TERM |
NON-TERM |
NON-TERM |
| signaling pathway |
TERM |
TERM |
TERM |
TERM |
TERM |
TERM |
| there are 121 non-terms in reference |
| there are 1179 terms in reference |
|
| TP(1060) | FP(112) | 1172 |
| FN(119) | TN(9) | 128 |
| 1179 | 121 | |
| note: high FP by SimpWeb is due to the extensiveness of the Web which overwhelms the much smaller contrastive corpus. |
| note: for example, general words such as application, duration, packaging, ever after restricting their search together with the seed terms "transcription factor" "blood cell" "human", still yield much higher document frequency compared to the contrastive corpus. |
|
| TP(1137) | FP(5) | 1142 |
| FN(42) | TN(116) | 158 |
| 1179 | 121 | |
|
| TP(767) | FP(49) | 816 |
| FN(412) | TN(72) | 484 |
| 1179 | 121 | |
| note: the high FN by BootCat is obviously due to its inadequate content. true terms are not classified as terms by BootCat due to inadequate word frequency. |
|
| TP(1054) | FP(37) | 1091 |
| FN(125) | TN(84) | 209 |
| 1179 | 121 | |
|
| TP(1179) | FP(0) | 1179 |
| FN(0) | TN(121) | 121 |
| 1179 | 121 | |